Getting to lung rehab can be difficult for older adults with COPD, so Seattle startup Kivo Health brings the sessions into ...
Kivo Health, an AI-powered virtual care company transforming how seniors manage chronic disease, announced an oversubscribed $10 million Series A led by Allumia Ventures, with participation from ...
Kivo Health announced the Series A round this week, aiming to expand a program that pairs live, therapist-led video sessions ...
They explained that COPD could not be diagnosed through the basic test alone, but that the reporter's lung function needed to ...
United Therapeutics, the Silver Spring, Maryland, and, North Carolina, developer of treprostinil-based therapies for lung ...
Good morning, and welcome to the Bolt Biotherapeutics Conference Call and Webcast. Please note that this call is being recorded and will be available for replay on boltbio.com. [Operator Instructions] ...
The new research, published in ERJ Open Research, found that nearly one in five asthma patients and one in three COPD ...
A systematic review of reviews finds that evidence on barriers and facilitators to digital medicine in chronic respiratory ...
PRA-216 is a novel IL-4Rα/TSLP bispecific antibody currently in Phase 2 development for asthma, COPD, and atopic dermatitis, with a Phase 2 study in EoE planned; patient data from all four trials ...
Bolt Biotherapeutics Inc. (Nasdaq: BOLT) has acquired clinical-stage biotechnology company Prana Therapies in a ...
At-home virtual care provider Kivo Health raised $10 million in Series A funding, bringing its overall financing to $16 million to fuel national ...
Participants receiving L-arginine plus liposomal vitamin C had a significantly greater reduction in FSS scores than those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results